A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis

Non-randomised trial OA: bronze CC0 ⤵ 35 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study compared the efficacy of a gonadotropin-releasing hormone agonist to a continuous oral contraceptive pill for treating bladder endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A prospective comparative clinical trial was done in a tertiary referral center for the treatment of endometriosis in 10 patients with bladder detrusor endometriosis: five were treated with a continuous oral contraceptive (OC) and another five with a GnRH agonist. Continuous OC therapy may be effective in the short-term treatment of bladder endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosisbladder_endometriosis

MeSH descriptors

Contraceptives, Oral Endometriosis Gonadotropin-Releasing Hormone Urinary Bladder Urinary Bladder Diseases Contraceptives, Oral Contraceptives, Oral Endometriosis Endometriosis Endometriosis Female Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Humans Prospective Studies Prospective Studies Time Factors Time Factors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (2)

Cited by (33)

Source provenance

europepmc
last seen: 2026-10-17T06:09:56.316927+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:05:01.267406+00:00
License: CC0 · commercial use OK